Effect of Continuous Anterior Chest Compression on Ventilation/Perfusion Ratio and Hemodynamics
HemodyCACC
Evaluation of the Effects of Continuous Anterior Chest Compression on Ventilation/Perfusion Ratios and Hemodynamics in SDRA
1 other identifier
interventional
20
1 country
1
Brief Summary
Intro: The mortality of acute respiratory distress syndrome (ARDS) remains high (40%), and may be aggravated by ventilation-induced lung injury (VILI), the main mechanisms of which are:
- 1.Anterior region overdistension,
- 2.Atelectrauma in the posterior regions. Positive expiratory pressure (PEEP) adjusted on the ventilator during ARDS aims to recruit posterior pulmonary territories in order to limit atelectrauma but is accompanied by a concomitant risk of overdistension of anterior territories.
- 3.Improves ventilation/perfusion ratios by decreasing both anterior territory dead space effect and posterior territory shunt,
- 4.Induce an improvement in cardiac output by decreasing right ventricular afterload (decrease in capillary compression related to the overdistension of the anterior territories and decrease in hypoxic vasoconstriction of the condensed territories).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2023
CompletedStudy Start
First participant enrolled
February 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedFirst Posted
Study publicly available on registry
November 21, 2024
CompletedJanuary 15, 2026
January 1, 2026
1.3 years
February 28, 2023
January 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
percentage of areas with normal VA/Q ratios, areas of shunt and areas of dead space effect.
demonstration that CACC may improve VA/Q ratio by using electrical impedance tomography
28 days
Secondary Outcomes (6)
CACC may induce a modification in cardiac output by decreasing right ventricular afterload
28 days
CACC may induce a modification in patient with right ventricular injury
28 days
CACC may induce a modification in right systolic function
28 days
CACC may induce a modification in left systolic function
28 days
CACC may induce a modification in ventilation distribution
28 days
- +1 more secondary outcomes
Study Arms (1)
Patient with moderate to severe ARDS under sedation andcontinuous curarization
EXPERIMENTALPatient with moderate to severe ARDS under sedation andcontinuous curarization
Interventions
CACC is performed manually and the pressure applied will be maintained between 60 and 80 cmH2O.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- ARDS moderate to severe according to the Berlin criteria
- Patient receiving continuous sedation and curarization
- Free and informed consent from the patient or family member
You may not qualify if:
- Pregnancy
- Adult patient subject to a legal protection measure (tutor, curator, etc.)
- Patients with a pacemaker, automatic implantable cardioverter defibrillator,
- Contraindications to thoracic belt placement (e.g., thoracic or spinal cord trauma, recent thoracic surgery)
- Undrained pneumothorax, bronchopleural fistula
- Hemodynamic instability (i.e., use of intravenous fluids of more than 10 mL/kg or vasopressors 2 mg/h of norepinephrine or 0.5 mg/h of epinephrine)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Henri Mondor hospital
Créteil, Creteil, 94010, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 28, 2023
First Posted
November 21, 2024
Study Start
February 28, 2023
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
January 15, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
DATAS ARE OWN BY ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, PLEASE CONTACT SPONSOR FOR FURTHER INFORMATION